SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

2023 Supreme(Del) 1534

AMIT BANSAL
Sun Pharma Laboratories Ltd. – Appellant
Versus
Cian Healthcare Ltd. – Respondent


Advocates appeared:
Mr. Sachin Gupta and Ms. Yashi Agrawal, Advocates, for the Plaintiff.
None, for the Defendant.

JUDGMENT

Amit Bansal, J. (Oral)

1. The present suit has been filed seeking the relief of permanent injunction restraining the defendant from the infringement of the trademark of the plaintiff, passing off their goods as those of the plaintiff and other ancillary reliefs.

FACTUAL MATRIX

2. The case set up in the plaint is as under:

2.1. The plaintiff company is a wholly owned subsidiary of Sun Pharma Industries Ltd. and is engaged in the business of marketing drugs and pharmaceutical combinations in over 150 countries with 45 manufacturing sites in various countries.

2.2. The plaintiff is the registered proprietor of the trademark "Maxgalin" bearing No. 1402291 since 29th November, 2005 and various other marks, details of which are provided in paragraph 9 of the plaint.

2.3. The "Maxgalin" mark is used by the plaintiff for its medicine used to relieve neuropathic pain. The said drug is sold in the form of tablets and is a Schedule H drug.

2.4. The trademark "Maxgalin" has also acquired goodwill and reputation due to its extensive and continuous use since 2005 and has therefore attained the status of a well-known trademark within the meaning of Section 2(1)(zg) of the Trade Marks Act

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon telegram-icon
whatsapp-icon Back to top